Roger Paredes, MD, PhD, is Head of the Infectious Diseases Department, Hospital Germans Trias i Pujol and Principal Investigator of the Microbial Genomics Group at the IrsiCaixa AIDS Research Institute, Badalona, Catalonia, Spain. He obtained an MD, PhD degree in Medicine and Surgery from the Autonomous University of Barcelona (UAB) and specialised in HIV research at the Brigham & Women’s Hospital, Harvard Medical School, through a La Caixa grant for postgraduate studies. His team at irsiCaixa has demonstrated the clinical utility of HIV-1 deep sequencing in both high- and low-income countries, and is now leading pioneering research into the role of the gut microbiome in the pathogenesis of HIV infection and chronic inflammation. During the COVID-19 pandemic, Dr Paredes has been the Spanish National Coordinator of seminal NIH/NIAID-funded randomized clinical trials, including ACTT-1 and 2 and the ACTIV-3/TICO platform, which have defined the current standard of care for this disease in hospitalized patients as well as in outpatients. Dr. Paredes is member of the COVID-19 treatment guidelines of the Spanish ID Society and the Catalan Institute of Health. He is also member of the WHO Global Clinical Platform for COVID-19 Clinical Advisory Group and serves in the WHO’s HIV Drug Resistance Strategy Steering Committee, the HIV treatment guidelines group and the European Laboratory Initiative.
Roger Paredes, MD, PhD
Biography
Related programs
-
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
-
European Meeting on HIV & Hepatitis 2019
-
European HIV Clinical Forum 2018
-
Gulf HIV Clinical Forum 2019
-
Brazilian HIV Forum Educational Series 2018
-
Rio de Janeiro HIV Clinical Forum 2020
-
European Meeting on HIV & Hepatitis 2018
-
HIV Clinical Forum 2021 (Example 2020 - Final Look)
-
European Workshop on Healthy Living with HIV 2017
-
European Meeting on HIV & Hepatitis 2021
-
Update on Integrase Inhibitors
-
Russian HIV Clinical Series 2021
-
São Paulo HIV Clinical Forum 2021
-
European Meeting on HIV & Hepatitis 2022
-
Managing HIV Patients With Limited Treatment Options 2021
-
GCC HIV Clinical Forum 2021
-
Argentinian HIV Clinical Forum 2022
-
Viral Infections & Inflammation Workshop 2022
-
Demystifying Long COVID International Conference 2023
-
Demystifying Long COVID International Conference 2024
-
2e Nederlandse Long COVID Dag 2025
Position
Hospital Germans Trias & IrsiCaixa AIDS Research Institute, Spain